CLINICAL_TRIALS
trial_result
· 2016-03-03
Clinical Trial Update: Atorvastatin to Prevent Avascular Necrosis of Bone in Steroid Treated Exacerbated Systemic Lupus Erythematosus [Phase 2]
Summary
Phase 2 trial investigating atorvastatin to prevent avascular necrosis in steroid-treated patients with systemic lupus erythematosus was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: NYU Langone Health | Conditions: Avascular Necrosis | Phase 2 | Status: TERMINATED | Results posted: 2016-03-03